Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China · Delayed Price · Currency is CNY

45.75

-1.32 (-2.80%)

Mar 9, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Inter-Segment Elimination	-3.89B	-	-	-	-
Sichuan Haisco merger entity	812.39M	-	-	-	-
Shenyang Haisco	189.55M	-	-	-	-
Liaoning Haisco	716.07M	-	-	-	-
Parent Company	3.17B	-	-	-	-
Xichang Haisco	1.14B	-	-	-	-
Consolidated Entity of Tibet Haisco Pharmaceutical	1.56B	-	-	-	-
Total	3.69B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	3.72B	3.36B	3.02B	2.77B	3.33B
China Growth	10.92%	11.27%	8.73%	-16.71%	-15.44%
Total	3.72B	3.36B	3.02B	2.77B	3.33B
Total Growth	10.92%	11.27%	8.73%	-16.71%	-15.44%

Source: S&P Global Market Intelligence.